Table 3.
6-Wk Intervention |
12-Wk Intervention
|
|||||||
---|---|---|---|---|---|---|---|---|
HFSED | HFEX | LFSED | LFEX | HFSED | HFEX | LFSED | LFEX | |
n | 5 | 7 | 5 | 6 | 12 | 13 | 14 | 14 |
Glucose, mmol/l | 13.27±0.6a | 10.51±0.30b | 11.50±0.66a,b | 11.43±0.85a,b | 12.87±0.43a | 10.88±0.29b,c | 11.75±0.45a,b | 9.52±0.34c* |
Insulin, μIU/ml | 15.95±1.8a | 10.23±0.4b | 10.78±1.1b | 7.90±0.7b | 24.52±4.7a | 20.91±3.4a,b | 13.96±1.1a,b* | 12.61±1.3b* |
HOMA-IR | 9.41±1.2a | 4.77±0.2b | 5.39±0.6b | 4.07±0.5b | 14.08±2.8a | 10.15±1.7a,b* | 7.34±0.7b | 5.4±0.6b |
Glucose AUC | 49,563±800a | 42,210±2,243a,b | 35,019±2,235b,c | 30,555±2,805c | 47,182±1,925a | 46,648±2,608a | 37,733±1,941b | 35,418±2,439b |
Values are means ± SE. HOMA-IR, homeostatic model of insulin resistance; AUC, area under the curve. All variables except glucose AUC were measured in the fasted state (12 h of no food). Different letters represent significant between-group differences within time point based on ANOVA with post hoc Tukey's test.
Significant duration effect within group.